Search Results - "Imatinib"

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines by Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X

Connect to this object online.

Deciphering the mechanism of Indirubin and its derivatives in the inhibition of Imatinib resistance using a "drug target prediction-gene microarray analysis-protein network construction" strategy by Huayao Li, Lijuan Liu, Jing Zhuang, Cun Liu, Chao Zhou, Jing Yang, Chundi Gao, Gongxi Liu, Changgang Sun

Connect to this object online.

Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature by Rohit Gulati, Yaser Alkhatib, Vijayalakshmi Donthireddy, Michelle Madden Felicella, Madhu P. Menon, Kedar V. Inamdar

Connect to this object online.

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely by Ohyashiki JH, Ohtsuki K, Mizoguchi I, Yoshimoto T, Katagiri S, Umezu T, Ohyashiki K

Connect to this object online.

Análise de mutações do domínio BCR-ABL quinase em pacientes com leucemia mielóide crônica refratários ao tratamento com mesilato de imatinibe by Laine Celestino Pinto, Lívia de Oliveira Sales, Tereza Cristina de Brito Azevedo, Caroline Aquino Moreira-Nunes, José Alexandre Rodrigues Lemos

Connect to this object online.

A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells by Patricia Martín-Rodríguez, Borja Guerra, Idaira Hueso-Falcón, Haidee Aranda-Tavío, Juan Díaz-Chico, José Quintana, Francisco Estévez, Bonifacio Díaz-Chico, Angel Amesty, Ana Estévez-Braun, Leandro Fernández-Pérez

Connect to this object online.

A systematic review and network meta-analysis of the efficacy and safety of third-line and over third-line therapy after imatinib and TKI resistance in advanced gastrointestinal stromal tumor by Xianhao Xiao, Weiye Yuan, Chong Wang, He Song

Connect to this object online.

Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib by Chiara Dalle Fratte, Michela Guardascione, Elena De Mattia, Eugenio Borsatti, Roberta Boschetto, Angelo Farruggio, Vincenzo Canzonieri, Vincenzo Canzonieri, Loredana Romanato, Rachele Borsatti, Sara Gagno, Elena Marangon, Maurizio Polano, Angela Buonadonna, Giuseppe Toffoli, Erika Cecchin

Connect to this object online.

Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report by Toshihisa Kimura MD, PhD, Tamotsu Togawa MD, Kenji Onishi MD, PhD, Atsushi Iida MD, PhD, Yasunori Sato MD, PhD, Takanori Goi MD, PhD

Connect to this object online.

Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes by Kadivar A, Kamalidehghan B, Akbari Javar H, Karimi B, Sedghi R, MI Noordin

Connect to this object online.

PPFIA1-targeting miR-181a mimic and saRNA overcome imatinib resistance in BCR-ABL1-independent chronic myeloid leukemia by suppressing leukemia stem cell regeneration by Rui Su, Chuting Li, Xiuyuan Wang, Zhendong Li, Ziqi Wen, Zhao Yin, Guiping Huang, Yanjun Liu, Juhua Yang, Haiyan Hu, Hong Nie, Keda Zhang, Jia Fei

Connect to this object online.

Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion by Egle Stukaite-Ruibiene, Rimvydas Norvilas, Rimvydas Norvilas, Vaidas Dirse, Sigita Stankeviciene, Goda Elizabeta Vaitkeviciene, Goda Elizabeta Vaitkeviciene

Connect to this object online.

Global identification of circular RNAs in imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145/miR-203/ABL1 and circ 0051886/miR-637/ABL1 by Yao-hua Lu, Zhong-yi Huang

Connect to this object online.

Myeloid/Lymphoid Neoplasms with ETV6::PDGFRB Fusion Gene: A Rare Case of Poor Response to Imatinib and Possible Transformation Mechanisms from Myeloid Neoplasms of Bone Marrow to T-Cell Lymphoblastic Lymphoma Invasion in Lymph Nodes by Gou Y, Tang Y, Liu S, Cheng S, Deng X, Wen Q, Feng Y, Peng X, Wang P, Zhang X

Connect to this object online.

Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer.... by Li-qian Ci, Zhi-gang Huang, Feng-mei Lv, Jun Wang, Ling-lin Feng, Feng Sun, Shui-juan Cao, Zhe-peng Liu, Yu Liu, Gang Wei, Wei-yue Lu

Connect to this object online.

Paediatric Formulation: Design and Development

Subjects: “…imatinib…”
DOAB: download the publication
DOAB: description of the publication

Multimodal Therapy of Upper Gastrointestinal Malignancies

Subjects: “…imatinib…”
DOAB: download the publication
DOAB: description of the publication

Transmucosal Absorption Enhancers in the Drug Delivery Field by Maher, Sam

Subjects: “…imatinib…”
DOAB: download the publication
DOAB: description of the publication

Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression

Subjects: “…imatinib…”
DOAB: download the publication
DOAB: description of the publication

Treatment free remission in pediatric chronic myeloid leukemia by Meena Satishkumar, Vellaichamy Swaminathan Venkateswaran, Ganesan Kavitha, Duraisamy Suresh, Chakraborty Sohini, Uppuluri Ramya, Raj Revathi

Connect to this object online.